This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Edwards’ heart-valve delivery patent revoked by EPO after Meril challenge

( May 16, 2025, 08:49 GMT | Official Statement) -- MLex Summary: Edwards Lifesciences' patent on a catheter-based heart-valve delivery system has been revoked by the European Patent Office, after Meril GmbH challenged it. The EPO's Boards of Appeal found that the patent's scope was broader than what was originally disclosed. The EPO also rejected late amendments. This decision follows a related case involving a sister divisional application in the same patent family, which was also revoked for similar reasons.The decision is attached. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections